Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

RSS icon
mark cuban pharmacy benefits managers

Mark Cuban to CEOs: ‘If you’re using a Big 3 pharmacy benefits manager, you are getting ripped off. Period. End of story.’

The White House held a roundtable discussion on lowering healthcare costs last week. Fortune magazine followed up with one of the panelists, business mogul and Cost Plus Drugs cofounder Mark Cuban.

hospital price transparency

Transparency report called ‘irresponsible,’ ‘reckless’

Have hospitals really taken a step backward along their march toward price transparency? Or is the watchdog outfit making the claim playing fast and loose with the facts?

semaglutide wegovy Novo Nordisk major adverse cardiovascular events

A big win for Wegovy: Weight loss drug semaglutide first in history to gain FDA approval for reducing heart risks

The FDA made a special announcement about its decision, describing the news as "a major advance for public health."

change healthcare cyberattack

Change Healthcare cyberattack: A recap and update in 10 quotes

“This is what happens when everything merges and you only have one option.”

Thumbnail

Some older patients taking aspirin to prevent CVD may be doing more harm than good

“Aspirin is no longer a one-size-fits-all preventive tool for older adults," according to one specialist with Michigan Medicine. 

The rapid rise of artificial intelligence (AI) has helped cardiologists, radiologists, nurses and other healthcare providers embrace precision medicine in a way that ensures more heart patients are receiving personalized care.

AI helps cardiologists deliver personalized healthcare—but there is still plenty of work to do

A new scientific statement from the American Heart Association explores the many ways AI and machine learning are being used to improve care for heart patients.

FDA announces new Class I recall of drainage systems after 26 injuries

According to the agency, using these devices “may cause serious injuries or death.”

Dexcom, a global healthcare technology company based out of San Diego, has received U.S. Food and Drug Administration (FDA) clearance for Stelo, a wearable glucose biosensor that can be obtained without a prescription.

FDA clears first over-the-counter wearable device for continuous glucose monitoring

The newly cleared device is worn on the back of the arm and sends data directly to the user's smartphone. 

Displaying 873 - 880 of 1603
Design by Adaptive Theme